Anzeige
Mehr »
Login
Freitag, 20.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Revolutionäre Zukunftsaktie: Ihr Depot-Booster für bahnbrechende Renditen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
394 Leser
Artikel bewerten:
(2)

Ohh-Med Medical Ltd.: Ohh-Med Medical Launches Ohh-Med UK to expand the worldwide reach of Vertica, the company's home-use device for treating erectile dysfunction

Finanznachrichten News

TIBERIAS, Israel, Sept. 7, 2023 /PRNewswire/ -- Ohh-Med Medical, a medtech startup located in the Tiberias Industrial Zone, has recently launched Ohh-Med UK, a wholly owned subsidiary located in England, to sell, market, and support sales of the Vertica medical device throughout the United Kingdom. Located in London, Ohh-Med UK will operate a dedicated Call centre for Customer Sales and Support to provide customers in the UK with the highest level of support.

Ohh-Med develops, manufactures and markets Vertica, a breakthrough medical device designed to improve the lives of thousands of men who experience erectile dysfunction (ED) or want to improve their erectile function. Thousands of satisfied customers are already enjoying the results of Vertica, and their testimonials attest to its success.

The company began sales of Vertica in the beginning of 2022 and received the CE-MDR approval to market throughout the EU in December of the same year. The company markets its product in Israel direct to consumers through its online shop and dedicated Call centre, and in Europe through a growing network of distributors.

Daniel Lischinsky, Ohh-Med Founder and CEO, explained the significance of the establishment of Ohh-Med UK, "We are expanding our successful sales model to the UK, complete with Call centre and Customer Support. Our experience in Israel selling thousands of medical devices through our sophisticated Call centre and online shop has convinced me that we can copy this success in the United Kingdom, which is a huge market for Vertica."

He continued, "The timing is perfect as the results of our first clinical study, showing more than 85% success rate, have recently been published in a leading scientific journal, the IJIR - International Journal of Impotence Research, a member of the Nature group of publications. Now we have the scientific proof to support what our customers have been saying all along - Vertica is changing their lives, restoring confidence and intimacy in their relationships."

About Ohh-Med

Ohh-Med Ltd, an Israeli medtech startup, develops, manufactures, and markets a growing suite of advanced, patented medical devices designed to treat male erectile dysfunction (ED). Established in Israel, the company was founded in 2017 by Daniel Lischinsky, a serial medtech entrepreneur, who also serves as the company's CEO.

Ohh-Med's advanced medical devices are targeted to both the consumer and professional healthcare markets. Vertica®, the company's flagship device, is a non-invasive, easy-to-use device for use at home to treat erectile dysfunction. Implementing radiofrequency technology, the patented device is designed to restore the natural erectile mechanism by improving collagen quality in the penile erectile tissues.

The company began sales of Vertica during 2022 and received the European CE MDR to market in Europe in December of the same year. The company markets its products in Israel through its online shop and advanced Call centre, and through a growing network of international distributors.

For more information, please contact:

Sandra Ziv
+972-54-8051001

info@ohhmed.com, info@ohhmed.co.uk
Ohhmed.com, vertica-labs.com, vertica-labs.com/uk

Cision View original content:https://www.prnewswire.co.uk/news-releases/ohh-med-medical-launches-ohh-med-uk-to-expand-the-worldwide-reach-of-vertica-the-companys-home-use-device-for-treating-erectile-dysfunction-301919658.html

© 2023 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.